Anteris Technologies Ltd (Anteris Technologies), formerly Admedus Ltd develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. The company’s product portfolio includes ADAPT technology, a next generation bio scaffold that reengineers xenograft tissue into a pure collagen scaffold and DurAVR heart valve, a 3D single piece aortic valve that creates a wider valve opening and better blood flow. Anteris Technologies is headquartered in Brisbane, Queensland, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Anteris Technologies Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Anteris Technologies Ltd Company Overview
- Anteris Technologies Ltd Company Snapshot
- Anteris Technologies Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Anteris Technologies Ltd - Pipeline Analysis Overview
- Business Description
- Anteris Technologies Ltd - Key Facts
- Anteris Technologies Ltd - Major Products and Services
- Anteris Technologies Ltd Pipeline Products by Development Stage
- Anteris Technologies Ltd Ongoing Clinical Trials by Trial Status
- Anteris Technologies Ltd Pipeline Products Overview
- ADAPT - Carotid Artery Repair
- ADAPT - Carotid Artery Repair Product Overview
- ADAPT - Dura Mater Repair
- ADAPT - Dura Mater Repair Product Overview
- ADAPT - Half Pipe Conduit
- ADAPT - Half Pipe Conduit Product Overview
- ADAPT - Jugular Vein
- ADAPT - Jugular Vein Product Overview
- ADAPT - Pediatric Leaflets
- ADAPT - Pediatric Leaflets Product Overview
- ADAPT - Samurai
- ADAPT - Samurai Product Overview
- ADAPT - Whole Vascular Tissue
- ADAPT - Whole Vascular Tissue Product Overview
- ADAPT Based Device - Orthopedics
- ADAPT Based Device - Orthopedics Product Overview
- ComASUR Transfemoral Delivery System
- ComASUR Transfemoral Delivery System Product Overview
- DurAVR Heart Valve
- DurAVR Heart Valve Product Overview
- DurAVR Heart Valve Clinical Trial
- DurAVR Leaflet Repair (RP)
- DurAVR Leaflet Repair (RP) Product Overview
- DurAVR THV System
- DurAVR THV System Product Overview
- DurAVR THV System Clinical Trial
- GyneCel
- GyneCel Product Overview
- Anteris Technologies Ltd - Key Competitors
- Anteris Technologies Ltd - Key Employees
- Anteris Technologies Ltd - Key Employee Biographies
- Anteris Technologies Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Anteris Technologies Ltd, Recent Developments
- Jan 05, 2022: Anteris strengthens its IP portfolio with new patent application for ADAPT
- Sep 06, 2021: Anteris appoints chief medical officer
- Feb 16, 2021: Anteris Technologies to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
- Jul 09, 2020: Anteris Technologies to host TAVR key opinion leader symposium moderated by Matt Miksic of Credit Suisse on July 20th, 2020
- May 19, 2020: Anti-calcification comparison study
- Jan 22, 2020: First-in-human SAVR trial begins Q1 2020
- Jul 31, 2019: Admedus: Quarterly Report - Appendix 4C for the period to JUNE 2019
- May 08, 2019: Facility agreement signed with Sio Partners
- May 08, 2019: Facility agreement signed with Sio Partners
- Apr 26, 2019: Admedus: Quarterly Report - Appendix 4C for the period to 31 March 2019
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Anteris Technologies Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Anteris Technologies Ltd Pipeline Products by Equipment Type
- Anteris Technologies Ltd Pipeline Products by Indication
- Anteris Technologies Ltd Ongoing Clinical Trials by Trial Status
- Anteris Technologies Ltd, Key Facts
- Anteris Technologies Ltd, Major Products and Services
- Anteris Technologies Ltd Number of Pipeline Products by Development Stage
- Anteris Technologies Ltd Pipeline Products Summary by Development Stage
- Anteris Technologies Ltd Ongoing Clinical Trials by Trial Status
- Anteris Technologies Ltd Ongoing Clinical Trials Summary
- ADAPT - Carotid Artery Repair - Product Status
- ADAPT - Carotid Artery Repair - Product Description
- ADAPT - Dura Mater Repair - Product Status
- ADAPT - Dura Mater Repair - Product Description
- ADAPT - Half Pipe Conduit - Product Status
- ADAPT - Half Pipe Conduit - Product Description
- ADAPT - Jugular Vein - Product Status
- ADAPT - Jugular Vein - Product Description
- ADAPT - Pediatric Leaflets - Product Status
- ADAPT - Pediatric Leaflets - Product Description
- ADAPT - Samurai - Product Status
- ADAPT - Samurai - Product Description
- ADAPT - Whole Vascular Tissue - Product Status
- ADAPT - Whole Vascular Tissue - Product Description
- ADAPT Based Device - Orthopedics - Product Status
- ADAPT Based Device - Orthopedics - Product Description
- ComASUR Transfemoral Delivery System - Product Status
- ComASUR Transfemoral Delivery System - Product Description
- DurAVR Heart Valve - Product Status
- DurAVR Heart Valve - Product Description
- DurAVR Heart Valve - First in Human Surgical Implantation of Single Piece ADAPT Treated 3D ALR (Aortic Leaflet Repair), Feasibility and Clinical Safety Study
- DurAVR Leaflet Repair (RP) - Product Status
- DurAVR Leaflet Repair (RP) - Product Description
- DurAVR THV System - Product Status
- DurAVR THV System - Product Description
- DurAVR THV System - Use of DurAVR THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study
- DurAVR THV System - Use of DurAVR THV System in Subjects with Severe Aortic Stenosis: First In Human Study
- GyneCel - Product Status
- GyneCel - Product Description
- Anteris Technologies Ltd, Key Employees
- Anteris Technologies Ltd, Key Employee Biographies
- Anteris Technologies Ltd, Subsidiaries
- Glossary
- Anteris Technologies Ltd Pipeline Products by Equipment Type
- Anteris Technologies Ltd Pipeline Products by Development Stage
- Anteris Technologies Ltd Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Nexstim Plc
- Biotron Ltd
- Benitec Biopharma Inc
- Medtronic Australasia Pty Ltd
- Biotron Ltd
- Nexstim Plc
- Benitec Biopharma Inc
- Medtronic Australasia Pty Ltd
- Medsonix Inc
